Bucalo Louis R Md - Net Worth and Insider Trading

Bucalo Louis R Md Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Bucalo Louis R Md owns 1 companies in total, including Titan Pharmaceuticals Inc (TTNP) .

Click here to see the complete history of Bucalo Louis R Md’s form 4 insider trades.

Insider Ownership Summary of Bucalo Louis R Md

Ticker	Comapny	Transaction Date	Type of Owner
TTNP	Titan Pharmaceuticals Inc	2004-02-09	director & President and CEO

Bucalo Louis R Md Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Bucalo Louis R Md Ownership Network

Ownership Network List of Bucalo Louis R Md

No Data

Ownership Network Relation of Bucalo Louis R Md

Bucalo Louis R Md Owned Company Details

What does Titan Pharmaceuticals Inc do?

Who are the key executives at Titan Pharmaceuticals Inc?

Bucalo Louis R Md is the director & President and CEO of Titan Pharmaceuticals Inc. Other key executives at Titan Pharmaceuticals Inc include 10 percent owner Seow Gim Shen , 10 percent owner Sire Group Ltd. , and director & President and COO Katherine Beebe .

Titan Pharmaceuticals Inc (TTNP) Insider Trades Summary

Over the past 18 months, Bucalo Louis R Md made no insider transaction in Titan Pharmaceuticals Inc (TTNP). Other recent insider transactions involving Titan Pharmaceuticals Inc (TTNP) include a net sale of 7,495,936 shares made by David E. Lazar ,

In summary, during the past 3 months, insiders sold 0 shares of Titan Pharmaceuticals Inc (TTNP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 374,797 shares of Titan Pharmaceuticals Inc (TTNP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 374,797 shares.

Titan Pharmaceuticals Inc (TTNP)'s detailed insider trading history can be found in Insider Trading Tracker table.

Titan Pharmaceuticals Inc Insider Transactions

No Available Data

Bucalo Louis R Md Mailing Address

Above is the net worth, insider trading, and ownership report for Bucalo Louis R Md. You might contact Bucalo Louis R Md via mailing address: C/o Titan Pharmaceuticals Inc, 400 Oyster Point Blvd, S San Francisco Ca 94080.

Discussions on Bucalo Louis R Md

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.